Predictive Performance of Urine Neutrophil Gelatinase-Associated Lipocalin for Dialysis Requirement and Death Following Cardiac Surgery in Neonates and Infants

被引:27
|
作者
Bojan, Mirela [1 ]
Vicca, Stephanie [2 ]
Lopez-Lopez, Vanessa [1 ]
Mogenet, Agnes [3 ]
Pouard, Philippe [1 ]
Falissard, Bruno [4 ,5 ,6 ]
Journois, Didier [5 ,7 ]
机构
[1] Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Dept Anesthesiol & Crit Care, F-75015 Paris, France
[2] Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Dept Biochem, F-75015 Paris, France
[3] CIC Ctr Necker Cochin, Assistance Publ Hop Paris, Unite Rech Clin, Paris, France
[4] Univ Paris Sud, INSERM, Paris, France
[5] Paris Descartes Univ, Paris, France
[6] Hop Paul Brousse, Hop Paris, Villejuif, France
[7] Georges Pompidou European Hosp, Assistance Publ Hop Paris, Dept Anesthesiol & Crit Care, Paris, France
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 02期
关键词
ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; CONGENITAL HEART-DISEASE; PERITONEAL-DIALYSIS; BIOMARKERS; OUTCOMES; INITIATION; MORTALITY; DIAGNOSIS; CHILDREN;
D O I
10.2215/CJN.04730513
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Urine neutrophil gelatinase-associated lipocalin (uNGAL) has been shown to accurately predict and allow early detection of AKI, as assessed by an increase in serum creatinine in children and adults. The present study explores the accuracy of uNGAL for the prediction of severe AKI-related outcomes in neonates and infants undergoing cardiac surgery: dialysis requirement and/or death within 30 days. Design, setting, participants, & measurements Prospective, observational cohort study conducted in a tertiary referral pediatric cardiac intensive care unit, including 75 neonates and 125 infants undergoing surgery with cardiopulmonary bypass between August 1, 2010, and May 31, 2011. Urine samples were collected before surgery and at median of five time points within 48 hours of bypass. Urine NGAL was quantified as absolute concentration, creatinine-normalized concentration, and absolute excretion rate, and a clusterization algorithm was applied to the individual uNGAL kinetics. The accuracy for the prediction of the outcome was assessed using receiver-operating characteristic areas, likelihood ratios, diagnostic odds ratios, net reclassification index, integrated reclassification improvement, and number needed to screen. Results A total of 1176 urine samples were collected. Of all patients, 8% required dialysis and 4% died. Three clusters of uNGAL kinetics were identified, including patients with significantly different outcomes. The uNGAL level peaked between 1 and 3 hours of bypass and remained high in half of all patients who required dialysis or died. The uNGAL levels measured within 24 hours of bypass accurately predicted the outcome and performed best after normalization to creatinine, with varying cutoffs according to the time elapsed since bypass. The number needed to screen to correctly identify the risk of dialysis or death in one patient varied between 1.5 and 2.6 within 12 hours of bypass. Conclusions uNGAL is a valuable predictive tool of dialysis requirement and death in neonates and infants with AKI after cardiac surgery.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 50 条
  • [1] Urine neutrophil gelatinase-associated lipocalin in asphyxiated neonates: a prospective cohort study
    Essajee, Farida
    Were, Fred
    Admani, Bashir
    PEDIATRIC NEPHROLOGY, 2015, 30 (07) : 1189 - 1196
  • [2] Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Neonates
    Chen, Chi-Nien
    Chou, Chia-Hung
    Jeng, Suh-Fang
    Tsai, I-Jung
    Chen, Pau-Chung
    Chen, Chien-Yi
    Chou, Hung-Chieh
    Tsao, Po-Nien
    Hsieh, Wu-Shiun
    PEDIATRICS AND NEONATOLOGY, 2016, 57 (03) : 207 - 212
  • [3] The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
    Arie Passov
    Liisa Petäjä
    Marjut Pihlajoki
    Ulla-Stina Salminen
    Raili Suojaranta
    Antti Vento
    Sture Andersson
    Ville Pettilä
    Alexey Schramko
    Eero Pesonen
    BMC Nephrology, 20
  • [4] The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
    Passov, Arie
    Petaja, Liisa
    Pihlajoki, Marjut
    Salminen, Ulla-Stina
    Suojaranta, Raili
    Vento, Antti
    Andersson, Sture
    Pettila, Ville
    Schramko, Alexey
    Pesonen, Eero
    BMC NEPHROLOGY, 2019, 20 (1)
  • [5] Dynamics of urine neutrophil gelatinase-associated lipocalin in cardiac surgery patients in the near term after surgery
    Sagatov, Inkar Y.
    Medeubekov, Ulugbek S.
    CHIRURGIA-ITALY, 2019, 32 (02): : 59 - 61
  • [6] Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts Acute Kidney Injury After Pediatric Cardiac Surgery
    Jose Alcaraz, Andres
    Augusta Gil-Ruiz, Maite
    Castillo, Ana
    Lopez, Jorge
    Romero, Carlos
    Nicole Fernandez, Sarah
    Carrillo, Angel
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : 121 - 130
  • [7] Economic impact and cost-effectiveness of urine neutrophil gelatinase-associated lipocalin following cardiac surgery
    A Shaw
    D Chalfin
    Critical Care, 14 (Suppl 1):
  • [8] Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of cardiac surgery associated acute kidney injury
    Liebetrau, Christoph
    Doerr, Oliver
    Baumgarten, Heike
    Gaede, Luise
    Szardien, Sebastian
    Blumenstein, Johannes
    Rolf, Andreas
    Moellmann, Helge
    Hamm, Christian
    Walther, Thomas
    Nef, Holger
    Weber, Michael
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (05) : 392 - 399
  • [9] Urine neutrophil gelatinase-associated lipocalin in asphyxiated neonates: a prospective cohort study
    Farida Essajee
    Fred Were
    Bashir Admani
    Pediatric Nephrology, 2015, 30 : 1189 - 1196
  • [10] Urine neutrophil gelatinase-associated lipocalin and other biomarkers in infants with urinary tract infection and in febrile controls
    Valdimarsson, Sindri
    Jodal, Ulf
    Barregard, Lars
    Hansson, Sverker
    PEDIATRIC NEPHROLOGY, 2017, 32 (11) : 2079 - 2087